S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals! (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Bill Gates is raving about WHAT?! (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Bill Gates is raving about WHAT?! (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals! (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Bill Gates is raving about WHAT?! (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Bill Gates is raving about WHAT?! (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals! (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Bill Gates is raving about WHAT?! (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Bill Gates is raving about WHAT?! (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals! (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Bill Gates is raving about WHAT?! (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Bill Gates is raving about WHAT?! (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app

Dawson James Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Dawson James. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Dawson James.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Daré Bioscience, Inc. stock logo
DARE
Daré Bioscience
$0.35
+0.8%
1/30/2024Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralLowView details for Dawson James rating of Daré Bioscience (NASDAQ:DARE) on 1/30/2024
Byrna Technologies Inc. stock logo
BYRN
Byrna Technologies
$9.84
+10.7%
9/27/2023Downgraded byDawson James-Buy -> NeutralLowView details for Dawson James rating of Byrna Technologies (NASDAQ:BYRN) on 9/27/2023
Byrna Technologies Inc. stock logo
BYRN
Byrna Technologies
$9.84
+10.7%
7/12/2023Target Lowered byDawson James-$9.50 -> $7.25LowView details for Dawson James rating of Byrna Technologies (NASDAQ:BYRN) on 7/12/2023
Kartoon Studios Inc. stock logo
TOON
Kartoon Studios
$1.27
+1.6%
7/11/2023Target Lowered byDawson James-$12.50 -> $10.00LowView details for Dawson James rating of Kartoon Studios (NASDAQ:TOON) on 7/11/2023
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
$0.51
+10.3%
3/17/2023Reiterated byDawson JamesAnalyst J. KolbertBuyLowView details for Dawson James rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/17/2023
Smith Micro Software, Inc. stock logo
SMSI
Smith Micro Software
$0.77
-5.2%
2/28/2023Target Lowered byDawson James-$8.30 -> $3.50LowView details for Dawson James rating of Smith Micro Software (NASDAQ:SMSI) on 2/28/2023
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
$0.31
-20.3%
2/13/2023Downgraded byDawson James-Buy -> NeutralN/AView details for Dawson James rating of Sorrento Therapeutics (NASDAQ:SRNE) on 2/13/2023
Zomedica Corp. stock logo
ZOM
Zomedica
$0.13
+1.3%
1/6/2023Initiated byDawson JamesAnalyst J. KolbertBuy$6.00N/AView details for Dawson James rating of Zomedica (NYSEAMERICAN:ZOM) on 1/6/2023
Check-Cap Ltd. stock logo
CHEK
Check-Cap
$2.20
+0.9%
9/15/2022Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralLowView details for Dawson James rating of Check-Cap (NASDAQ:CHEK) on 9/15/2022
Byrna Technologies Inc. stock logo
BYRN
Byrna Technologies
$9.84
+10.7%
9/8/2022Target Lowered byDawson James-$12.00 -> $9.50LowView details for Dawson James rating of Byrna Technologies (NASDAQ:BYRN) on 9/8/2022
ProPhase Labs, Inc. stock logo
PRPH
ProPhase Labs
$5.24
-0.2%
7/21/2022Downgraded byDawson James-Neutral -> SellLowView details for Dawson James rating of ProPhase Labs (NASDAQ:PRPH) on 7/21/2022
Dyadic International, Inc. stock logo
DYAI
Dyadic International
$1.38
7/18/2022Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralLowView details for Dawson James rating of Dyadic International (NASDAQ:DYAI) on 7/18/2022
Byrna Technologies Inc. stock logo
BYRN
Byrna Technologies
$9.84
+10.7%
4/26/2022Initiated byDawson James-Buy$12.00HighView details for Dawson James rating of Byrna Technologies (NASDAQ:BYRN) on 4/26/2022
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
$1.08
3/11/2022Reiterated byDawson JamesAnalyst Jason KolbertBuy$6.00N/AView details for Dawson James rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/11/2022
Smith Micro Software, Inc. stock logo
SMSI
Smith Micro Software
$0.77
-5.2%
3/11/2022Target Lowered byDawson James-Buy$11.40 -> $8.30HighView details for Dawson James rating of Smith Micro Software (NASDAQ:SMSI) on 3/11/2022
Profire Energy, Inc. stock logo
PFIE
Profire Energy
$1.46
3/9/2022Target Raised byDawson James-$1.65 -> $2.00LowView details for Dawson James rating of Profire Energy (NASDAQ:PFIE) on 3/9/2022
Know Labs, Inc. stock logo
KNWN
Know Labs
$2.53
-3.4%
2/8/2022Initiated byDawson James-Buy$7.00HighView details for Dawson James rating of Know Labs (OTCMKTS:KNWN) on 2/8/2022
Check-Cap Ltd. stock logo
CHEK
Check-Cap
$2.20
+0.9%
2/7/2022Upgraded byDawson James-Neutral -> BuyHighView details for Dawson James rating of Check-Cap (NASDAQ:CHEK) on 2/7/2022
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
$0.38
-4.3%
12/22/2021Reiterated byDawson JamesAnalyst J. KolbertNeutralMediumView details for Dawson James rating of Brainstorm Cell Therapeutics (NASDAQ:BCLI) on 12/22/2021
Vuzix Co. stock logo
VUZI
Vuzix
$1.68
-0.6%
12/21/2021Initiated byDawson James-Buy$15.00MediumView details for Dawson James rating of Vuzix (NASDAQ:VUZI) on 12/21/2021
ProPhase Labs, Inc. stock logo
PRPH
ProPhase Labs
$5.24
-0.2%
10/13/2021Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralMediumView details for Dawson James rating of ProPhase Labs (NASDAQ:PRPH) on 10/13/2021
Profire Energy, Inc. stock logo
PFIE
Profire Energy
$1.46
8/5/2021Initiated byDawson JamesAnalyst James McIlreeBuy$1.65HighView details for Dawson James rating of Profire Energy (NASDAQ:PFIE) on 8/5/2021
Smith Micro Software, Inc. stock logo
SMSI
Smith Micro Software
$0.77
-5.2%
8/5/2021Initiated byDawson James-Buy$11.10HighView details for Dawson James rating of Smith Micro Software (NASDAQ:SMSI) on 8/5/2021
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
$5.78
+1.6%
6/21/2021Target Raised byDawson James-Buy$19.00 -> $35.00LowView details for Dawson James rating of Anavex Life Sciences (NASDAQ:AVXL) on 6/21/2021
Check-Cap Ltd. stock logo
CHEK
Check-Cap
$2.20
+0.9%
3/17/2021Reiterated byDawson JamesAnalyst J. KolbertBuy -> Neutral$40.00LowView details for Dawson James rating of Check-Cap (NASDAQ:CHEK) on 3/17/2021
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
$0.66
+7.6%
2/25/2021Reiterated byDawson JamesAnalyst J. KolbertBuy$6.00LowView details for Dawson James rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 2/25/2021
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
$1.87
+3.9%
2/17/2021Target Raised byDawson James-Buy$240.00 -> $315.00LowView details for Dawson James rating of Fortress Biotech (NASDAQ:FBIO) on 2/17/2021
ProPhase Labs, Inc. stock logo
PRPH
ProPhase Labs
$5.24
-0.2%
1/20/2021Initiated byDawson James-Buy$25.00HighView details for Dawson James rating of ProPhase Labs (NASDAQ:PRPH) on 1/20/2021
Lineage Cell Therapeutics, Inc. stock logo
LCTX
Lineage Cell Therapeutics
$1.08
10/12/2020Reiterated byDawson James-Buy$6.00N/AView details for Dawson James rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 10/12/2020
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
$0.66
+7.6%
9/17/2020Reiterated byDawson JamesAnalyst J. KolbertBuyLowView details for Dawson James rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 9/17/2020
Daré Bioscience, Inc. stock logo
DARE
Daré Bioscience
$0.35
+0.8%
7/12/2020Reiterated byDawson James-Buy$3.00HighView details for Dawson James rating of Daré Bioscience (NASDAQ:DARE) on 7/12/2020
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
$5.78
+1.6%
6/8/2020Reiterated byDawson James-Buy$16.00MediumView details for Dawson James rating of Anavex Life Sciences (NASDAQ:AVXL) on 6/8/2020
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
$0.31
-20.3%
5/26/2020Initiated byDawson James-Buy -> Buy$24.00LowView details for Dawson James rating of Sorrento Therapeutics (NASDAQ:SRNE) on 5/26/2020
Cytosorbents Co. stock logo
CTSO
Cytosorbents
$1.02
3/9/2020Reiterated byDawson James-Buy$15.00 -> $17.00HighView details for Dawson James rating of Cytosorbents (NASDAQ:CTSO) on 3/9/2020
Dyadic International, Inc. stock logo
DYAI
Dyadic International
$1.38
2/26/2020Reiterated byDawson JamesAnalyst Jason KolbertBuyHighView details for Dawson James rating of Dyadic International (NASDAQ:DYAI) on 2/26/2020
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$1.01
+2.0%
1/14/2020Reiterated byDawson JamesAnalyst J. KolbertBuy -> NeutralLowView details for Dawson James rating of IMAC (NASDAQ:IMAC) on 1/14/2020
Mesoblast Limited stock logo
MESO
Mesoblast
$1.82
+1.1%
12/19/2019Initiated byDawson JamesAnalyst Jason KolbertBuy$28.00LowView details for Dawson James rating of Mesoblast (NASDAQ:MESO) on 12/19/2019
Check-Cap Ltd. stock logo
CHEK
Check-Cap
$2.20
+0.9%
12/5/2019Initiated byDawson James-Buy$80.00LowView details for Dawson James rating of Check-Cap (NASDAQ:CHEK) on 12/5/2019
Dyadic International, Inc. stock logo
DYAI
Dyadic International
$1.38
10/16/2019Initiated byDawson James-Buy$14.00LowView details for Dawson James rating of Dyadic International (NASDAQ:DYAI) on 10/16/2019
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
$0.66
+7.6%
9/6/2019Initiated byDawson JamesAnalyst Jason KolbertBuy$7.00N/AView details for Dawson James rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 9/6/2019
Fortress Biotech, Inc. stock logo
FBIO
Fortress Biotech
$1.87
+3.9%
8/26/2019Initiated byDawson James-Buy$285.00HighView details for Dawson James rating of Fortress Biotech (NASDAQ:FBIO) on 8/26/2019
ADMA Biologics, Inc. stock logo
ADMA
ADMA Biologics
$5.24
+1.4%
8/12/2019Downgraded byDawson JamesAnalyst J. KolbertBuy -> Neutral$4.00HighView details for Dawson James rating of ADMA Biologics (NASDAQ:ADMA) on 8/12/2019
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
$5.78
+1.6%
7/24/2019Initiated byDawson JamesAnalyst J. KolbertBuy$16.00LowView details for Dawson James rating of Anavex Life Sciences (NASDAQ:AVXL) on 7/24/2019
inTEST Co. stock logo
INTT
inTEST
$11.81
+1.6%
12/28/2018Reiterated byDawson JamesAnalyst B. SineBuyHighView details for Dawson James rating of inTEST (NYSE:INTT) on 12/28/2018
SilverSun Technologies, Inc. stock logo
SSNT
SilverSun Technologies
$14.94
+11.7%
12/19/2018Reiterated byDawson JamesAnalyst B. SineBuyHighView details for Dawson James rating of SilverSun Technologies (NASDAQ:SSNT) on 12/19/2018
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
$0.38
-4.3%
12/18/2018Reiterated byDawson JamesAnalyst J. KolbertBuyHighView details for Dawson James rating of Brainstorm Cell Therapeutics (NASDAQ:BCLI) on 12/18/2018
WidePoint Co. stock logo
WYY
WidePoint
$2.87
-1.4%
12/3/2018Reiterated byDawson JamesAnalyst B. SineBuyHighView details for Dawson James rating of WidePoint (NYSEAMERICAN:WYY) on 12/3/2018
Wireless Telecom Group, Inc. stock logo
WTT
Wireless Telecom Group
$2.13
12/3/2018Reiterated byDawson JamesAnalyst B. SineBuyLowView details for Dawson James rating of Wireless Telecom Group (NYSEAMERICAN:WTT) on 12/3/2018
Cineverse Corp. stock logo
CNVS
Cineverse
$1.47
+2.8%
10/22/2018Initiated byDawson JamesAnalyst B. SineBuyLowView details for Dawson James rating of Cineverse (NASDAQ:CNVS) on 10/22/2018
Fennec Pharmaceuticals Inc. stock logo
FRX
Fennec Pharmaceuticals
C$13.40
+0.5%
10/10/2018Reiterated byDawson JamesAnalyst C. WertherBuyN/AView details for Dawson James rating of Fennec Pharmaceuticals (TSE:FRX) on 10/10/2018
Fennec Pharmaceuticals Inc stock logo
FENC
Fennec Pharmaceuticals
$10.16
+0.3%
10/11/2018Initiated byDawson JamesAnalyst C. WertherBuyHighView details for Dawson James rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 10/11/2018
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$7.66
+2.1%
10/2/2018Initiated byDawson JamesAnalyst B. SineBuyLowView details for Dawson James rating of Luna Innovations (NASDAQ:LUNA) on 10/2/2018
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$0.54
+1.3%
9/4/2018Initiated byDawson JamesAnalyst R. WassermanBuyHighView details for Dawson James rating of STRATA Skin Sciences (NASDAQ:SSKN) on 9/4/2018
Veru Inc. stock logo
VERU
Veru
$0.38
-7.6%
6/25/2018Reiterated byDawson JamesAnalyst R. WassermanBuyMediumView details for Dawson James rating of Veru (NASDAQ:VERU) on 6/25/2018
IMV Inc. stock logo
IMV
IMV
C$1.12
-1.8%
6/19/2018Reiterated byDawson JamesAnalyst C. WertherBuyN/AView details for Dawson James rating of IMV (TSE:IMV) on 6/19/2018
LiveOne, Inc. stock logo
LVO
LiveOne
$1.40
-6.0%
6/4/2018Reiterated byDawson JamesAnalyst B. SineBuyMediumView details for Dawson James rating of LiveOne (NASDAQ:LVO) on 6/4/2018
Altimmune, Inc. stock logo
ALT
Altimmune
$10.44
+7.7%
5/29/2018Reiterated byDawson JamesAnalyst R. WassermanBuyHighView details for Dawson James rating of Altimmune (NASDAQ:ALT) on 5/29/2018
Acasti Pharma Inc. stock logo
ACST
Acasti Pharma
$2.45
1/29/2018Reiterated byDawson JamesAnalyst R. WassermanBuyLowView details for Dawson James rating of Acasti Pharma (NASDAQ:ACST) on 1/29/2018
CEL-SCI Co. stock logo
CVM
CEL-SCI
$2.46
-13.7%
10/16/2017Reiterated byDawson JamesAnalyst R. WassermanNeutralN/AView details for Dawson James rating of CEL-SCI (NYSE:CVM) on 10/16/2017
PAVmed Inc. stock logo
PAVM
PAVmed
$1.82
+8.3%
9/5/2017Reiterated byDawson JamesAnalyst R. WassermanBuy$151.50HighView details for Dawson James rating of PAVmed (NASDAQ:PAVM) on 9/5/2017
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
$10.43
-0.2%
8/3/2017Reiterated byDawson JamesAnalyst R. WassermanBuyHighView details for Dawson James rating of ESSA Pharma (NASDAQ:EPIX) on 8/3/2017
Onconova Therapeutics, Inc. stock logo
ONTX
Onconova Therapeutics
$0.70
+2.2%
7/25/2017Reiterated byDawson JamesAnalyst R. WassermanBuyHighView details for Dawson James rating of Onconova Therapeutics (NASDAQ:ONTX) on 7/25/2017
CEL-SCI Co. stock logo
CVM
CEL-SCI
$2.46
-13.7%
3/11/2016Reiterated byDawson JamesAnalyst R. WassermanBuyN/AView details for Dawson James rating of CEL-SCI (NYSE:CVM) on 3/11/2016
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$1.35
2/9/2016Reiterated byDawson JamesAnalyst R. WassermanBuyN/AView details for Dawson James rating of Enzo Biochem (NYSE:ENZ) on 2/9/2016
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$49.33
+3.9%
5/6/2015Initiated byDawson James-Buy$952.50N/AView details for Dawson James rating of Soleno Therapeutics (NASDAQ:SLNO) on 5/6/2015
CEL-SCI Co. stock logo
CVM
CEL-SCI
$2.46
-13.7%
3/2/2015Initiated byDawson James-Buy$3.00N/AView details for Dawson James rating of CEL-SCI (NYSE:CVM) on 3/2/2015
AxoGen, Inc. stock logo
AXGN
AxoGen
$9.88
+0.1%
5/14/2014Initiated byDawson James-Buy$5.00N/AView details for Dawson James rating of AxoGen (NASDAQ:AXGN) on 5/14/2014
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$14.36
-1.0%
5/14/2014Initiated byDawson James-Buy$6.00N/AView details for Dawson James rating of NeoGenomics (NASDAQ:NEO) on 5/14/2014
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
$1.66
+0.6%
10/9/2013Initiated byDawson James-Buy$3.75N/AView details for Dawson James rating of ARCA biopharma (NASDAQ:ABIO) on 10/9/2013
Agenus Inc. stock logo
AGEN
Agenus
$0.75
+7.3%
3/12/2013Reiterated byDawson James-BuyN/AView details for Dawson James rating of Agenus (NASDAQ:AGEN) on 3/12/2013
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$9.07
+0.9%
3/12/2013Downgraded byDawson James-Buy -> Neutral$80.00N/AView details for Dawson James rating of Pediatrix Medical Group (NYSE:MD) on 3/12/2013
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$32.56
+5.5%
2/26/2013Initiated byDawson James-Buy$4.00N/AView details for Dawson James rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 2/26/2013
Atossa Therapeutics, Inc. stock logo
ATOS
Atossa Therapeutics
$0.94
-0.5%
12/20/2012Initiated byDawson James-Outperform$120.00N/AView details for Dawson James rating of Atossa Therapeutics (NASDAQ:ATOS) on 12/20/2012
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$49.81
+2.3%
12/12/2012Reiterated byDawson James-Market Outperform$51.00N/AView details for Dawson James rating of Bristol-Myers Squibb (NYSE:BMY) on 12/12/2012
Amgen Inc. stock logo
AMGN
Amgen
$291.12
-1.3%
12/7/2012Initiated byDawson James-Outperform$91.00N/AView details for Dawson James rating of Amgen (NASDAQ:AMGN) on 12/7/2012
The GEO Group, Inc. stock logo
GEO
The GEO Group
$11.56
-3.8%
12/4/2012Downgraded byDawson James-Market PerformN/AView details for Dawson James rating of The GEO Group (NYSE:GEO) on 12/4/2012
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$126.87
-0.4%
11/27/2012Initiated byDawson James-OutperformN/AView details for Dawson James rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/27/2012
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$1.30
+5.7%
11/27/2012Initiated byDawson James-Outperform$132.00N/AView details for Dawson James rating of Rockwell Medical (NASDAQ:RMTI) on 11/27/2012
Agenus Inc. stock logo
AGEN
Agenus
$0.75
+7.3%
11/27/2012Initiated byDawson James-OutperformN/AView details for Dawson James rating of Agenus (NASDAQ:AGEN) on 11/27/2012
SELLAS Life Sciences Group, Inc. stock logo
SLS
SELLAS Life Sciences Group
$0.78
+0.2%
11/27/2012Initiated byDawson James-Outperform$150.00N/AView details for Dawson James rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 11/27/2012
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$76.94
-2.5%
11/27/2012Downgraded byDawson James-OutperformN/AView details for Dawson James rating of Cytokinetics (NASDAQ:CYTK) on 11/27/2012
Galectin Therapeutics Inc. stock logo
GALT
Galectin Therapeutics
$1.69
+3.7%
7/6/2012Target Lowered byDawson James-Buy$3.00N/AView details for Dawson James rating of Galectin Therapeutics (NASDAQ:GALT) on 7/6/2012
Netflix, Inc. stock logo
NFLX
Netflix
$561.32
+0.5%
10/28/2011Target Lowered byDawson James-Sell$16.50 -> $7.14N/AView details for Dawson James rating of Netflix (NASDAQ:NFLX) on 10/28/2011

MarketBeat Community Rating for Dawson James

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  22,983 (Vote Outperform)
Underperform Votes:  19,676 (Vote Underperform)
Total Votes:  42,659
MarketBeat's community ratings are surveys of what our community members think about Dawson James and other research firms. Vote "Outperform" if you believe Dawson James's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Dawson James's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

My Account -